Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A69CF724 | — |
A patient has been given Priorix diluent at a local GP; patient has been given Priorix diluent; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) (batch number A69CF724) and (batch number A69CE762A) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: A patient has been given Priorix diluent at a local GP) and inappropriate dose of vaccine administered (Verbatim: patient has been given Priorix diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 19-MAY-2025 The reporter reported that a patient had been given Priorix diluent at a local General Practitioner. They need to identify which patients received it, they have 18 vaccinations and 17 of them have batch numbers recorded as A69CF724 and one is recorded as A69CE762A. Could this be the number off the diluent. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.